ATE143372T1 - Substance p antagoniste - Google Patents

Substance p antagoniste

Info

Publication number
ATE143372T1
ATE143372T1 AT90912128T AT90912128T ATE143372T1 AT E143372 T1 ATE143372 T1 AT E143372T1 AT 90912128 T AT90912128 T AT 90912128T AT 90912128 T AT90912128 T AT 90912128T AT E143372 T1 ATE143372 T1 AT E143372T1
Authority
AT
Austria
Prior art keywords
amino acid
acid residue
peptide
active site
analog
Prior art date
Application number
AT90912128T
Other languages
English (en)
Inventor
David H Coy
Jacques-Pierre Moreau
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Application granted granted Critical
Publication of ATE143372T1 publication Critical patent/ATE143372T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/22Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT90912128T 1989-08-16 1990-08-16 Substance p antagoniste ATE143372T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39472789A 1989-08-16 1989-08-16

Publications (1)

Publication Number Publication Date
ATE143372T1 true ATE143372T1 (de) 1996-10-15

Family

ID=23560172

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90912128T ATE143372T1 (de) 1989-08-16 1990-08-16 Substance p antagoniste

Country Status (15)

Country Link
EP (1) EP0438566B1 (de)
JP (1) JPH04502922A (de)
AT (1) ATE143372T1 (de)
CA (1) CA2039175A1 (de)
CZ (2) CZ285562B6 (de)
DD (1) DD298411A5 (de)
DE (1) DE69028692T2 (de)
DK (1) DK0438566T3 (de)
ES (1) ES2094160T3 (de)
GR (1) GR900100613A (de)
HU (1) HUT65465A (de)
IE (1) IE77033B1 (de)
PT (1) PT95016B (de)
SK (1) SK402890A3 (de)
WO (1) WO1991002745A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410019A (en) * 1987-09-24 1995-04-25 The Administrators Of The Tulane-Educational Fund Therapeutic peptides
FR2680174A1 (fr) * 1991-08-05 1993-02-12 Michelot Robert Nouveaux composes peptidiques, inhibiteurs de l'adsorption du virus hiv sur ses cellules cibles.
ATE195867T1 (de) 1991-09-20 2000-09-15 Glaxo Group Ltd Neue medizinische indikation für tachykinin- antagonisten
US6492330B1 (en) 1996-08-16 2002-12-10 National Institute Of Immunology Antiangiogenic drugs
US6156725A (en) * 1996-08-16 2000-12-05 National Institute Of Immunology Drug for the treatment of cancer
EP0835662B1 (de) * 1996-10-08 2001-11-14 National Institute of Immunology Arzneimittel zur Behandlung von Krebs
CA2225185A1 (en) * 1997-08-11 1999-02-11 Peter K. Law Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
JP2010516734A (ja) 2007-01-24 2010-05-20 グラクソ グループ リミテッド 3,5−ジアミノ−6−(2,3−ジクロロフェニル)−1,2,4−トリアジンまたはr(−)−2,4−ジアミノ−5−(2,3−ジクロロフェニル)−6−フルオロメチルピリミジンを含む医薬組成物
WO2011058982A1 (ja) * 2009-11-11 2011-05-19 国立大学法人山口大学 消化器疾患治療剤
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain
WO2023139542A1 (en) * 2022-01-21 2023-07-27 Institut Pasteur De Montevideo Active immunization for reducing osteoarthritic, neuropathic, and cancer pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862114A (en) * 1971-11-22 1975-01-21 Ici Australia Ltd Analogs of substance p
IT1212508B (it) * 1981-12-22 1989-11-22 Anic Spa Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
US4481139A (en) * 1983-04-13 1984-11-06 Board Of Regents, The University Of Texas System Peptide antagonists of substance P
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
NZ229552A (en) * 1988-06-20 1992-06-25 Merrell Dow Pharma Neurokinin a antagonists

Also Published As

Publication number Publication date
CZ402890A3 (cs) 1999-04-14
IE902958A1 (en) 1991-02-27
DE69028692T2 (de) 1997-02-20
WO1991002745A1 (en) 1991-03-07
EP0438566B1 (de) 1996-09-25
CA2039175A1 (en) 1991-02-17
JPH04502922A (ja) 1992-05-28
HUT65465A (en) 1994-06-28
ES2094160T3 (es) 1997-01-16
IE77033B1 (en) 1997-11-19
SK280796B6 (sk) 2000-07-11
PT95016A (pt) 1991-04-18
CZ285562B6 (cs) 1999-09-15
SK402890A3 (en) 2000-07-11
PT95016B (pt) 1997-05-28
GR900100613A (el) 1991-12-30
EP0438566A1 (de) 1991-07-31
DD298411A5 (de) 1992-02-20
CZ285319B6 (cs) 1999-07-14
DE69028692D1 (de) 1996-10-31
HU906872D0 (en) 1991-07-29
EP0438566A4 (en) 1993-03-31
DK0438566T3 (da) 1996-11-11

Similar Documents

Publication Publication Date Title
ATE139540T1 (de) Heilmittelpeptide
DK249489D0 (da) Therapeutisk virksomme peptider, isaer bombesinantagonistiske og litorinantagonistiske peptider samt fremgangsmaade til fremstilling deraf
DK66391A (da) Terapeutisk virksomme peptider
ATE143372T1 (de) Substance p antagoniste
DE69011102D1 (de) Hydrophobe bindungsstelle für adhäsionspeptide.
DE68929151D1 (de) Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
PT1288223E (pt) Derivados de peptidos terapeuticos
DE3750197D1 (de) Antagonisten des Fibroblasten-Wachstumsfaktors.
SE8008428L (sv) N-adamantansubstituerade tetrapeptidamider
MX9203175A (es) Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion.
ES2100960T3 (es) Estructura proteica de la toxina vegetal gelonina.
DK450187D0 (da) Fremgangsmaade til fremstilling af proteiner
DK1612555T3 (da) Kryptiske peptider til anvendelse til at inducere immunologisk tolerance
DK0404967T3 (da) Rekombinante C-terminal-alfa-amiderende enzym af human skjoldbruskkirtel-oprindelse
PT93320A (pt) Processo para a preparacao de peptideos terapeuticos
DE3665462D1 (en) Pharmacologically active peptides
DE3869939D1 (de) Biologisch wirksame peptide.
IT1274359B (it) Peptide sintetico ad attivita' antagonistica per la proteina chemiotattica dei monociti 1 (mcp-1)
ATE99909T1 (de) Elastomere polypeptide als vaskulare prothesematerialien.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee